New funding for cystic fibrosis research
Larry Lands, a senior scientist at The Institute, will lead a new project focusing on rare genetic mutations
Advancing Equity in Research
For Black History Month, patient partners, community actors, academics, and clinicians gathered at The Institute to address racism
New study reveals key mechanism behind natural resistance to tuberculosis
Researchers identify a unique immune response in the lungs that may help prevent tuberculosis infection...
Driving innovation in rare disease research: The Institute and RARE.Qc
New funding from Génome Québec will strengthen rare disease data infrastructure, accelerating research and discoveries
New global guideline on candidiasis features expertise from The Institute
Dr. Don Vinh, the only Canadian primary author, joins over 100 experts from 35 countries in this landmark effort
Engineered IL-2 molecule shows promise in treating autoimmune disease
Researchers from The Institute, in collaboration with Sanofi, develop a novel therapy to enhance immune regulation in...
D2R awards over $6 million to support Core Platforms
Three platforms at The Institute will benefit from new funding for innovation and sustainability
Ensuring everyone can fully participate in research and healthcare
The MUHC and The Institute’s accessibility plan is commended by the Office des personnes handicapées...
Fall 2024 CIHR competition results
Teams from The Institute received $18.4 million in project funding
American College of Rheumatology honours a trainee from The Institute
Leah Flatman’s research investigates risks associated with maternal medication exposure during pregnancy